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OBJECTIVE — Intramyocellular acetylcarnitine (IMAC) is involved in exercise-related fuel
metabolism. It is not known whether levels of systemic glucose inﬂuence IMAC levels in type 1
diabetes.
RESEARCH DESIGN AND METHODS — Seven male individuals with type 1 diabetes
performed 120 min of aerobic exercise at 55–60% of VO2max randomly on two occasions
(glucose clamped to 5 or 11 mmol/l, identical insulinemia). Before and after exercise, IMAC was
detected by
1H magnetic resonance spectroscopy in musculus vastus intermedius.
RESULTS — Postexercise levels of IMAC were signiﬁcantly higher than pre-exercise values in
euglycemia (4.30  0.54 arbitrary units [a.u.], P  0.001) and in hyperglycemia (2.44 
0.53 a.u., P  0.01) and differed signiﬁcantly according to glycemia (P  0.01). The increase in
exercise-related levels of IMAC was signiﬁcantly higher in euglycemia (3.97  0.45 a.u.) than in
hyperglycemia (1.71  0.50 a.u.; P  0.01).
CONCLUSIONS — The increase in IMAC associated with moderate aerobic exercise in
individuals with type 1 diabetes was signiﬁcantly higher in euglycemia than in hyperglycemia.
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I
ntramyocellular acetylcarnitine
(IMAC) is involved in the regulation of
fat and carbohydrate oxidation in skel-
etal muscle during moderate aerobic ex-
ercise(1).Althoughcarnitinemetabolism
appears comparable in patients with type
1 diabetes and healthy control subjects
(2), it is not known whether IMAC is re-
lated to variations in fuel metabolism ob-
served during exercise under differing
glycemic levels in type 1 diabetes (3).
Given the controversial results from pre-
vious studies linking IMAC to increased
-oxidation(4)butalsotohighglycolytic
ﬂux(1),theaimofthepresentstudywasto
assess exercise-related concentrations of
IMAC noninvasively by
1H magnetic reso-
nance spectroscopy (
1H MRS) (5,6) in pa-
tientswith type1diabetesineuglycemia
and hyperglycemia.
RESEARCH DESIGN AND
METHODS— This was a randomized
single-blind crossover study (3). Seven
physically active individuals with type 1
diabetes without relevant diabetes-
associated complications were investi-
gated(meanSEMage33.52.4years,
diabetes duration 20.1  3.6 years, A1C
6.7  0.2%, BMI 24.3  0.4 kg/m
2, and
VO2max 50.3  4.5 ml   min
1   kg
1). All
were treated with continuous subcutane-
ous insulin infusion (insulin dose 0.61 
0.05 units   kg
1   day
1). Participants
performed 120 min of exercise at 55–
60% of VO2max on two occasions in ran-
domorderwithglucoseclampedat5.4
0.5 mmol/l (euglycemia) or 11.0  0.3
mmol/l (hyperglycemia). Insulin infusion
(7 mU   m
2   min
1, range 5–8.2) was
equal during both conditions (3). Muscle
spectra were obtained with short echo
time
1H MRS from musculus vastus inter-
medius 81  2 and 83  2 min after
exercise in euglycemia and hyperglyce-
mia, respectively (NS). Acquisition pa-
rameters were clinical 1.5-T scanner (GE
Medical Systems, Waukesha WI), local-
izedvolumeof111218mm
3,point-
resolved spectroscopy localization,
repetition time 3 s, echo time 20 ms, two
spectra of 128 acquisitions, and water
presaturation. Spectra were analyzed us-
ing TDFDFit (7) with a ﬁt strategy opti-
mized for the acetylcarnitine-peak.
Acetylcarnitine content is expressed in
absolute arbitrary units (a.u.) relative to
the water signal intensity. Parameters are
expressed as means  SEM (median and
range where appropriate). All analyses
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StataCorp, College Station, TX).
RESULTS— Figure 1A displays the
summed spectra before and after exercise
and corresponding differences with the
acetyl peak of IMAC at 2.13 ppm. Pre-
exercise levels of IMAC did not differ sig-
niﬁcantlyaccordingtotheglycemiclevels
(0.33  0.21 and 0.73  0.33 a.u. for
euglycemia and hyperglycemia, respec-
tively; NS). Postexercise levels of IMAC
were signiﬁcantly higher than pre-
exercise values in euglycemia (4.30 
0.54 a.u.; P  0.001) and in hyperglyce-
mia (2.44  0.53 a.u.; P  0.01). In ad-
dition, postexercise levels differed
signiﬁcantly according to glycemia (P 
0.01).AsshowninFig.1B,thistranslated
into a signiﬁcantly higher increase of ex-
ercise-related levels of IMAC in euglyce-
mia (3.97  0.45 a.u.) compared with
that in hyperglycemia (1.71  0.50 a.u.;
P  0.01).
CONCLUSIONS — In the present
study, levels of IMAC were assessed non-
invasively in skeletal muscle of individu-
als with type 1 diabetes in euglycemia
and hyperglycemia before and after
moderate aerobic exercise. The princi-
palﬁndingwasasigniﬁcantlyhigherin-
crease in IMAC in euglycemia than in
hyperglycemia.
The effect of euglycemia and hyper-
glycemiaonexercise-relatedsubstrateox-
idation has also been assessed in healthy
individuals (8), however, without deter-
mination of IMAC. Still, previous reports
do not suggest genuinely different levels
of acylated carnitine in patients with type
1 diabetes compared with nondiabetic
control subjects (2). Conversely, a recent
study in patients with type 1 diabetes in-
vestigated levels of IMAC during exercise
in euglycemia but with differing insulin
levels (9). The authors reported a similar
increase in IMAC in euglycemia and hy-
perinsulinemia, implying that the ﬂux
through the pyruvate dehydrogenase
complex (PDC) is independent of insulin
concentrations (9). Taken together, these
results indicate that in individuals with
type 1 diabetes, levels of IMAC are inﬂu-
enced by the availability of energy sub-
strates, in particular systemic glucose,
whereaslevelsofinsulinseemtohaveless
inﬂuence.Ofnote,IMAChasbeenshown
to increase after a few minutes of high-
intensity exercise (10). This result has
been hypothesized to be due to the pro-
duction of acetyl-CoA exceeding its utili-
Figure 1—A:
1H magnetic resonance spectra were obtained from musculus vastus intermedius
beforeandafter120minofmoderate-intensityexerciseineuglycemiaorhyperglycemia.Summed
spectra are portrayed for pre- and postexercise. The difference spectra show positive peaks for the
acetyl group of IMAC at 2.13 ppm and its trimethylammonium (TMA) group at 3.2 ppm, as well
asnegativecontributionfromintramyocellularlipids(IMCL)(reducedlipidlevelsafterexercise).
The trimethylammonium resonance is not used in the present work because, as reported earlier
(5), its difference peak does not readily scale in intensity with the acetylcarnitine peak, probably
related to differences in molecular properties. Cr, methyl and methylene peaks of creatine/
phosphocreatine.Notethatinthesummedspectra,differentiationbetweenextramyocellularlipids
(EMCL) and intramyocellular lipids is difﬁcult, whereas all analyses were done in individual
spectra. B: Exercise-related differences in IMAC levels in euglycemia and hyperglycemia. Black
lines reﬂect individual results; bars reﬂect mean  SEM. Acetylcarnitine content is expressed in
absolute arbitrary units relative to the water signal obtained from separate reference scans. P
represents the comparison of differences in euglycemia vs. hyperglycemia.
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groups consequently being transferred to
carnitine by carnitine acetyltransferase,
whichresultsinincreasesinIMACaswell
as in free CoA (1). Although IMAC may
thus reﬂect the imbalance of the ﬂuxes
through the PDC and the Krebs cycle in
high-intensity exercise, its role during ex-
ercise at lower intensity or at rest is less
clear. Interestingly, previous studies in
healthy individuals (4) have suggested an
association of IMAC with increased -ox-
idation. Compatible with these ﬁndings,
the present study revealed a higher con-
tribution of net lipid oxidation to overall
substrate oxidation in euglycemia than in
hyperglycemia together with a tendency
toward increased consumption of in-
tramyocellular lipids in euglycemia (data
published in ref. 3). Whether this associ-
ation is due to a direct effect of substrate
ﬂuxes (e.g., increased glucose ﬂux in hy-
perglycemia compared with euglycemia)
on fuel metabolism or whether indirect
regulation of key enzymes (PDC and car-
nitine palmitoyltransferase 1) were in-
volved remains speculative because
noninvasive determination of IMAC pre-
cluded further analysis of intramyocellu-
lar metabolic pathways in the present
study.
The strength of the present analysis is
its strictly controlled design with stable
and identical insulin levels, systemic glu-
cose being the sole variable that has been
modiﬁed. The use of MRS allowed for a
repetitive, noninvasive measurement of
IMAC, although technical differences
limit the direct comparability of IMAC
levels in the present study with results
from muscle biopsies. We acknowledge
that our results are limited by the small
sample size. However, all individuals in
this study showed similar dynamics of
IMAC according to glycemia. Because of
the study design, magnetic resonance
spectra could not be obtained directly af-
ter completion of the exercise. However,
previous studies have shown that postex-
ercise levels of IMAC are remarkably sta-
ble for similar time periods (6). The
present study was performed in male in-
dividualswithtype1diabetesexclusively,
and the complex study design along with
the limited resources did not allow us to
include a control group of healthy indi-
viduals. Statements referring to a more
general population thus clearly remain
restrictive.
Insummary,inindividualswithwell-
controlled type 1 diabetes, an exercise-
related increase in IMAC was detected in
both glycemic conditions, but the effect
was signiﬁcantly higher in euglycemia
than in hyperglycemia. These ﬁndings
point to a role of IMAC as a marker of
exercise-related fuel metabolism in skele-
tal muscle.
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